ריזדרונט טבע ® 75 מ"ג

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Achète-le

Ingrédients actifs:

RISEDRONIC ACID SODIUM 75 MG

Disponible depuis:

ABIC MARKETING LTD

Code ATC:

M05BA07

forme pharmaceutique:

TABLETS

Mode d'administration:

PER OS

Fabriqué par:

TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY

Groupe thérapeutique:

RISEDRONIC ACID

indications thérapeutiques:

Treatment of osteoporosis in postmenopausal women at increased risk of fractures.Prevention of osteoporosis in postmenopausal women who are at risk of developing osteoporosis and for whom the desired clinical outcome is to maintain bone mass and to reduce the risk of fracture.

Date de l'autorisation:

2012-07-01

Rechercher des alertes liées à ce produit